SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-21-011121
Filing Date
2021-08-10
Accepted
2021-08-10 16:02:00
Documents
11
Period of Report
2021-09-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20210923xdef14a.htm DEF 14A 575801
2 GRAPHIC tmb-20210923xdef14a005.jpg GRAPHIC 737
3 GRAPHIC tmb-20210923xdef14a020.jpg GRAPHIC 27444
4 GRAPHIC tmb-20210923xdef14a006.jpg GRAPHIC 739
5 GRAPHIC tmb-20210923xdef14a010.jpg GRAPHIC 761
6 GRAPHIC tmb-20210923xdef14a003.jpg GRAPHIC 739
7 GRAPHIC tmb-20210923xdef14a023.jpg GRAPHIC 53875
8 GRAPHIC tmb-20210923xdef14a022.jpg GRAPHIC 54735
9 GRAPHIC tmb-20210923xdef14a001.jpg GRAPHIC 2323
10 GRAPHIC tmb-20210923xdef14a021.jpg GRAPHIC 4325
11 GRAPHIC tmb-20210923xdef14a002.jpg GRAPHIC 755
  Complete submission text file 0001558370-21-011121.txt   780325
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14778 | Film No.: 211159815
SIC: 2834 Pharmaceutical Preparations